Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

(2012) David Ebb et al.   JOURNAL OF CLINICAL ONCOLOGY

Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes

(2012) Steven E. Lipshultz et al.   JOURNAL OF CLINICAL ONCOLOGY

High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors

(2012) Helena J. van der Pal et al.   JOURNAL OF CLINICAL ONCOLOGY

The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium

(2011) Lynda M. Vrooman et al.   EUROPEAN JOURNAL OF CANCER

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

(2011) Henk Visscher et al.   JOURNAL OF CLINICAL ONCOLOGY

Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group

(2011) Javier G. Blanco et al.   JOURNAL OF CLINICAL ONCOLOGY

Screening for hereditary haemochromatosis

(2011) Itty M. Nadakkavukaran et al.   PATHOLOGY

Hemochromatosis Genotypes and Risk of Iron Overload—A Meta-Analysis

(2010) Adriana Maria Neghina et al.   ANNALS OF EPIDEMIOLOGY

Do Genetic Variations in Antioxidant Enzymes Influence the Course of Hereditary Hemochromatosis?

(2010) Pierre Nahon et al.   ANTIOXIDANTS & REDOX SIGNALING

Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation

(2010) Almudena Cascales et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council

(2010) Leo Lopez et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

(2010) Steven E Lipshultz et al.   LANCET ONCOLOGY

Therapeutic complications in a patient with high-risk acute lymphoblastic leukemia and undiagnosed hereditary hemochromatosis

(2010) Jay Michael S. Balagtas et al.   PEDIATRIC BLOOD & CANCER

Long-Term Survivors of Childhood Cancers in the United States

(2009) A. B. Mariotto et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)

(2009) L B Silverman et al.   LEUKEMIA

Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane

(2008) Elly V. Barry et al.   JOURNAL OF CLINICAL ONCOLOGY

Myocardial iron overload in transfusion-dependent pediatric patients with acute leukemia

(2008) K. Lutz et al.   PEDIATRIC BLOOD & CANCER